Establishments engaged in manufacturing, repacking, relabeling, or salvaging drugs for U.S. distribution are required to register with the FDA, with certain exemptions. This requirement underscores the regulatory framework that governs drug manufacturing and distribution in the United States.
Manufacturers and suppliers must ensure compliance with these registration requirements to avoid potential penalties and ensure uninterrupted operations. Understanding the nuances of these regulations could help companies streamline their registration processes and maintain compliance with FDA standards.
Source: fda.gov · Image: Silva Pharmaceuticals Ltd (Old factory), Maijdee, Noakhali, Bangladesh by Pharmacist Pleistocene, CC0, via Wikimedia Commons
Use the database as your supply chain compass →